How to Starve Cancer

Product Information

To her doctor’s utter amazement, it appeared that McLelland had beaten the odds once again. Nine months later, she was not only alive, but her cancer blood markers were good. McLelland’s cervical cancer markers were in the normal range. But in 2003, she received yet another death sentence: treatment-related myelodysplasia, a form of bone marrow mutation that may progress to leukemia. However, McLelland cautions that there is no one-size-fits-all approach. Her own experience with her various forms of cancer highlight that fact. Instead, McLelland’s approach focuses on learning which fuel sources your particular cancer uses—and then creating a targeted treatment plan based on that information. Jane is a long-term survivor of stage IV cancer. She is a former Chartered Physiotherapist who worked in the NHS and in private practice for 12 years. She is an award-winning author of How to Starve Cancer in which she describes her journey through cancer and her battle with infertility. She is best known for her Metro Map, a simple diagram of the complexity of cancer metabolism and for bringing the new approach of ferroptosis to the public. McLelland believed she had finally found out how to beat her cancer once and for all. And her test results proved her right. Blood tests revealed that her TM2PK tumor markers (a marker of abnormal glycolysis) had dropped from 397 to 21.5—just slightly above a “normal” reading of 15.

The first big gun was a cardiovascular drug called dipyridamole, which stops protein from getting into the cancer cell, a key factor in starving leukemia, according to McLelland. In her book, McLelland provides all the information a cancer patient might need to point them in the right direction for developing a protocol to starve their cancer.Jane is a natural revolutionary, a powerful speaker and a brave and passionate advocate of fellow cancer sufferers. She spends much of her day coordinating cancer care for patients, researching off label drugs and providing up to date information for her thousands of followers in her Facebook group.

I didn’t even think I was going to be alive, and I certainly didn’t expect to have a family,” said McLelland. “I have to pinch myself to believe it sometimes.” Jane was diagnosed with cervical cancer in 1994 and did conventional treatment. In 1999 her cancer progressed to stage IV and she started incorporating complementary and alternative treatments alongside chemotherapy. In 2004 she started developing leukemia as a result of the chemotherapy and/or radiotherapy treatments she received. I do believe we already have every drug and every supplement that we need to beat cancer. The key is getting the right combinations to people at the right time,” said McLelland. “Yes, in certain circumstances there can be too much damage to the body from the cancer itself. But if you can get to people before that, I cannot see why patients can’t be rescued even from advanced malignancies. Stage IV cancer should not be a death sentence, in my view.” Use short term. Concurrent use of a statin and Dipyridamole mitigates cardio effects and enhances efficacy. In this truly ground-breaking book, Jane takes us through her remarkable, heart-breaking journey, and the medical discoveries she made along the way. The use of ‘off label’ drugs for treating cancer is finally gaining traction. Yet Jane discovered these herself in 2003. Unbeknown to her, she would become ‘patient zero’.

Working Together

You have done a magnificent job in your course… you are providing more relevant information for patients than any other integrative medicine source or platform. You are establishing a way forward that is bringing truly relevant information for people diagnosed with cancer-and their families-and their physicians. For people currently struggling with a cancer diagnosis, McLelland has an important message: Never give up. I already knew that statins would be potentially useful against cervical cancer. But research had also shown that they caused apoptosis in acute myeloid leukemias. I also had overlooked the fact that NSAIDs could cause cell death (apoptosis),” said McLelland. “What I learned from the Life Extension article was that there was a synergy between the two drugs, making them far more potent when taken together.” In the early stages of her research, McLelland first learned that glucose feeds most cancers and that IGF-1 (an insulin-like growth factor hormone found in high levels in dairy and meat) also helped to drive its growth. After intensive research, McLelland concluded that all of these drugs would starve the cancer from different angles: dipyridamole cut off cancer’s access to protein, metformin cut off access to glucose, and the statin cut off access to fat. Once the cancer cells were in their weakened state, the addition of etodolac could help finish them off.